date,title,source
Nov-15-18,Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018,GlobeNewswire
Nov-15-18,Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results,GlobeNewswire
Dec-12-18,"Is Soleno Therapeutics, Inc.s (NASDAQ:SLNO) CEO Pay Justified?",Simply Wall St.
Dec-19-18,Soleno Therapeutics Announces $16.5 Million Private Placement,GlobeNewswire
Mar-11-19,Soleno Therapeutics to Participate in Two Upcoming Investor Conferences,GlobeNewswire
Mar-14-19,Soleno Therapeutics Announces Positive Outcome from Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome,Business Wire
Mar-15-19,Four Healthcare Stocks Picking Up Speed On Friday,ACCESSWIRE
Mar-15-19,Soleno Therapeutics News: Why SLNO Stock Is Skyrocketing Today,InvestorPlace
Mar-15-19,"The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA",Benzinga
